[1] Chamot AM, Benhamou CL, Kahn MF, et al.Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases[J]. Rev Rhum Mal Osteoartic, 1987, 54(3): 187-196. [2] Müller-Richter, UD, Roldán JC, Mörtl M, et al. SAPHO syndrome with ankylosis of the temporomandibular joint[J]. Int J Oral Maxillofac Surg, 2009, 38(12): 1335-1341. [3] Kahn MF, Hayem F, Fiayem C, et al.Is diffuse sclerosing osteotnyelitis of the mandible part of the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome?[J]. Oral Surg Oral Med Oral Pathol, 1994, 78(5): 594-598. [4] Fleuridas G, Teysseres N, Ragot JP, et al.Diffuse sclerosing osteomyelitis of the mandible and SAPHO syndrome[J]. Rev Stomatol Chir Maxillofac, 2002, 103(2): 96-104. [5] Hayem G, Bouchaud-Chabot A, Benali K, et al.SAPHO syndrome: a long-term follow-up study of 120 cases[J]. Semin Arthritis Rheum, 1999, 29(3): 159-171. [6] Carneiro S, Sampaio-Barros PD.SAPHO syndrome[J]. Rheum Dis Clin North Am, 2013, 39(2): 401-418. [7] Kahn MF, Khan MA.The SAPHO syndrome[J]. Baillieres Clin Rheumatol, 1994, 8(2): 333-362. [8] Kotilainen P, Gullichsen RE, Saario R, et al.Aseptic spondylitis as the initial manifestation of the SAPHO syndrome[J]. Eur Spine J, 1997, 6(5): 327-329. [9] Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P.Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome[J]. Rheumatology(Oxford), 2008, 47(8): 1160-1167. [10] Assmann G, Simon P.The SAPHO syndrome-are microbes involved?[J]. Best Prac Res Clin Rheumatol, 2011, 25(3): 423-437. [11] Paparo F, Revelli M, Semprini A, et al.Seronegative spondyloarthropathies: what radiologists should know[J]. Radiol Med, 2014, 119(3): 156-163. [12] Nguyen MT, Borchers A, Selmi C, et al.The SAPHO syndrome[J]. Semin Arthritis Rheum, 2012, 42(3): 254-265. [13] Assmann G, Wagner AD, Monika M, et al.Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome[J]. Rheumatol Int, 2010, 30(10): 1273-1276. [14] Golla A, Jansson A, Ramser J, et al.Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22[J]. Eur J Hum Genet, 2002, 10(3): 217-221. [15] Hurtado-Nedelec M, Chollet-Martin S, Chapeton D, et al.Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes[J]. J Rheumatol, 2010, 37(2): 401-409. [16] Queiro R, Moreno P, Sarasqueta C, et al, Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immune genetic profile[J]. Clin Exp Rheumatol, 2008, 26(1): 125-128. [17] Marí A, Morla A, Melero M, et al.Diffuse sclerosing osteomyelitis (DSO) of the mandible in SAPHO syndrome: a novel approach with anti-TNF therapy. Systematic review[J]. J Craniomaxillofac Surg, 2014, 42(8): 1990-1996. [18] Hayem G.Valuable lessons from SAPHO syndrome[J]. Joint Bone Spine, 2007, 74(2): 123-126. [19] Suei Y, Taguchi A, Tanimoto K: Diagnosis and classification of mandibular osteomyelitis[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2005, 100(2): 207-214. [20] Olivieri I, Padula A, Palazzi C.Pharmacological management of SAPHO syndrome[J]. Expert Opin Investig Drugs, 2006, 15(10): 1229-1233. [21] Hayem G, Bouchaud-Chabot A, Benali K, et al.SAPHO syndrome: a long-term follow-up study of 120 cases[J]. Semin Arthritis Rheum, 1999, 29(3): 159-171. [22] Wagner AD, Andresen J, Jendro MC, et al.Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome[J]. Arthritis Rheum, 2002, 46(7): 1965-1968. [23] Kopterides P, Pikazis D, Koufos C.Successful treatment of SAPHO syndrome with zoledronic acid[J]. Arthritis Rheum, 2004, 50(9): 2970-2973. [24] Galadari H, Bishop AG, Venna SS, et al.Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with acombination of isotretinoin and pamidronate[J]. J Am Acad Dermatol, 2009, 6l(1): 123-l25. [25] Hatano H, Shigeishi H, Higashikawa K, et al.A case of SAPHO syndrome with diffuse sclerosing osteomyelitis of the mandible treated successfully with prednisolone and bisphosphonate[J]. J Oral Maxillofac Surg, 2012, 70(3): 626-631. [26] Suei Y, Tanimoto K, Miyauchi M, et al.Partial resection of the mandible for the treatment of diffuse sclerosing osteomyelitis: report of four cases[J]. J Oral Maxillofac Surg, 1997, 55(4): 410-415. [27] Roldán JC, Terheyden H, Dunsche A, et al.Acne with chronic recurrent multifocal osteomyelitis involving the mandible as part of the SAPHO syndrome: case report[J]. Br J Oral Maxillofac Surg, 2001, 39(2): 141-144. [28] Zemann W, Pau M, Feichtinger M, et al.SAPHO syndrome with affection of the mandible: diagnosis, treatment, and review of literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2011, 111(2): 190-195. [29] Moll C, Hernández MV, Cañete JD, et al.Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature[J]. Semin Arthritis Rheum, 2008, 37(5): 299-306. [30] Reichardt LF, Pitak-Arnnop P, Hemprich A, et al.Chronic refractory osteomyelitis as a part of synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome: a diagnostic challenge[J]. ANZ J Surg, 2011, 81(9): 642-643. |